Clinical Trials


Name of TrialDescription
​The Gilead – DIVERSITY Study​A study to evaluate the efficacy and safety of the orally administered drug Filgotinib for the treatment of active Crohn’s disease.​ 
​Creatine Supplementation Study​​A study to evaluate dietary creatine supplementation for the reduction of mucosal inflammation through improved epithelial barrier function of active Ulcerative colitis.
​ADMIRE-CD II​A study to evaluate the safety and efficacy of Cx601, adult allogenic expanded adipose-derived stem cells, for the treatment of complex perianal fistula(s) in patients with Crohn’s disease.​
The Arena ELEVATE UC Study

 

A study to evaluate the safety and efficacy of etrasimod, an orally administered pill taken once daily, for the treatment of moderately to severely active ulcerative colitis. 
The Arena GLADIATOR UC Study

 

A study to evaluate the safety and efficacy of etrasimod, an orally administered pill taken once daily, for the treatment of moderately active ulcerative colitis. 

Please contact Lucy Smigiel for more information:
Email: Lucy.Smigiel@cuanschutz.edu​
Phone: 303-724-9143